See the DrugPatentWatch profile for lisdexamfetamine
What is Alvogen's Lisdexamfetamine?
Alvogen, Inc. markets a generic version of lisdexamfetamine dimesylate capsules, a medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adults [1]. This generic product is bioequivalent to the branded drug Vyvanse [2].
When Will Alvogen's Lisdexamfetamine Generic Be Available?
Alvogen has launched its generic lisdexamfetamine dimesylate capsules in the United States [1][2]. The availability of generic alternatives typically follows patent expirations or successful patent challenges for the branded drug [3].
How Does Generic Lisdexamfetamine Work?
Lisdexamfetamine is a prodrug that is converted in the body to dextroamphetamine, a central nervous system stimulant. Dextroamphetamine works by increasing the levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which are thought to play a role in regulating attention, impulse control, and hyperactivity [4].
What Are the Differences Between Branded and Generic Lisdexamfetamine?
Generic lisdexamfetamine capsules are chemically identical to the branded version and have the same active ingredient, dosage form, strength, route of administration, and intended use [2]. The primary difference lies in the inactive ingredients, which may vary between the generic and branded products, and the cost, with generics generally being more affordable [5].
What Other Companies Offer Generic Lisdexamfetamine?
Several other pharmaceutical companies also market generic versions of lisdexamfetamine dimesylate capsules. These include companies such as Teva Pharmaceuticals, Mylan, and others [6].
What Is the Patent Status of Lisdexamfetamine?
The patent landscape for lisdexamfetamine is complex and has been subject to litigation. DrugPatentWatch.com tracks patent information for many drugs, including lisdexamfetamine, providing details on patent expiration dates and any challenges [3].
What Are the Risks Associated with Lisdexamfetamine?
Like the branded version, generic lisdexamfetamine carries risks, including potential for abuse and dependence. It can also cause side effects such as insomnia, decreased appetite, dry mouth, and increased blood pressure. It is important to use lisdexamfetamine only as prescribed by a healthcare professional [4].
Who Regulates Generic Lisdexamfetamine?
The U.S. Food and Drug Administration (FDA) regulates generic drugs, including lisdexamfetamine. The FDA ensures that generic medications are safe, effective, and meet the same quality standards as their branded counterparts [5].
Sources:
1. https://www.alvogen.com/
2. https://www.drugs.com/imprints/alvogen-lisdexamfetamine-dimesylate-73074-0064-67-32692
3. https://drugpatentwatch.com/
4. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021444s027lbl.pdf
5. https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/generics-and-their-safety
6. https://www.goodrx.com/lisdexamfetamine